Reporting Period and Background Adverse events were reported to Pfizer during a 90-day period following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System Organ Classes (SOC), in other words, by systems in the body. Vaccine-Associated …

Reporting Period and Background Adverse events were reported to Pfizer during a 90-day period following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System Organ Classes (SOC), in other words, by systems in the body. Gender: …

Safety Concerns Identified by Pfizer Pfizer identified three categories of Safety Concerns in Table 3. These were: Important identified risks: Anaphylaxis (Table 4). Important potential risks: Vaccine-Associated Enhanced Disease (VAED), including Vaccine-Associated Enhanced Respiratory Disease (VAERD) (Table 5). Missing Information: Use in Pregnancy and Lactation, Use in Paediatric Individuals under …

Main Finding Of the 130 total patients in this SOC, 41 (32%) died. Of the 137 relevant events, 126 were categorized as serious. Main Findings Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the …

Main Finding Death was the “relevant event outcome” for 96 individuals, which is 7.8% of 1,223 deaths from all causes reported in this 90-day report. Main Findings Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. …

Main Findings Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System Organ Classes (SOC), in other words, by systems in the body. 3,600 cases were …

Main Findings Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System Organ Classes (SOC), in other words, by systems in the body. 32 cases were …

Main Findings Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System Organ Classes (SOC), in other words, by systems in the body. Of those whose …

Main Findings Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System Organ Classes (SOC), in other words, by systems in the body. Of those with …

Main Findings Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System Organ Classes (SOC), in other words, by systems in the body. Of the 69 …

Main Findings Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System Organ Classes (SOC), in other words, by systems in the body. The demographics of …

Main Finding Of the 542 neurological adverse events, 95% were defined as serious. 16 were fatal. Adverse Events were reported to Pfizer during a 90-day period, following the December 1, 2020, public rollout of its COVID-19 experimental “vaccine” product. In the Pfizer 5.3.6 document, these AEs were categorized by System …

Main Finding Infants and children under 12 were injected with the Pfizer “vaccine” seven months before the product was approved for children. The 5.3.6 document was compiled by Pfizer for the purpose of reporting adverse events to the FDA. The reporting period was during the first 90 days, starting December …

ABBREVIATIONS: 5.3.6: Pfizer source document SOC: System Organ Class AE: Adverse Event AESI: Adverse Event of Special Interest EUA: Emergency Use Authorization by FDA PM: Post-Marketing BNT162b2: Pfizer’s mRNA COVID-19 vaccine SEQUELAE: an abnormal condition resulting from a previous disease, injury, or other trauma AGE GROUPS defined in 5.3.6 (p. …

ABBREVIATIONS: 5.3.6: Pfizer source document SOC: System Organ Class AE: Adverse Event AESI: Adverse Event of Special Interest EUA: Emergency Use Authorization by FDA PM: Post-Marketing BNT162b2: Pfizer’s mRNA COVID-19 vaccine SEQUELAE: an abnormal condition resulting from a previous disease, injury, or other trauma AGE GROUPS defined in 5.3.6 (p. …

ABBREVIATIONS: 5.3.6: Pfizer source document SOC: System Organ Class AE: Adverse Event AESI: Adverse Event of Special Interest EUA: Emergency Use Authorization by FDA PM: Post-Marketing BNT162b2: Pfizer’s mRNA COVID-19 vaccine SEQUELAE: an abnormal condition resulting from a previous disease, injury, or other trauma AGE GROUPS defined in 5.3.6 (p. …

5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports Table 7. AESIs Evaluation for BNT162b2 AESIs Category (Primary Path) OR Respiratory failures (excl neonatal) (HLT) (Primary Path) OR Viral lower respiratory tract infections (HLT) (Primary Path) OR PTs: Acute respiratory distress syndrome; Endotracheal intubation; Hypoxia; Pulmonary haemorrhage; Respiratory disorder; Severe acute …

After years of half-truths and outright falsehoods, facts are emerging about SARS-CoV-2’s origins. The Wuhan Institute of Virology (WIV) purged important genome sequence information from its servers and was not forthcoming regarding their research, so complete details will never be known. Enough can be pieced together for objective molecular geneticists …

Albert Benavides has diligently documented techniques used by public health agencies to hide data in their databases. He has exposed the techniques of throttling, time displacement, and removal of all or parts of reports. Mr. Benavides posts frequently on Substack. This report will examine two cases drawn from Vaccine Adverse …

COVID-19 ‘vaccine’ drugs are modified mRNA gene therapy products. So, why did the FDA assign the review and recommendation responsibilities to the Vaccines and Related Biological Products Committee (VRBPAC) instead of the Cellular Tissue and Gene Therapy Advisory Committee (CTGTAC)? CTGTAC was the logical FDA advisory committee for such a …